News Releases

MEDIA ADVISORY: Press Preview to Highlight New Research, Featured Speakers for American Psychiatric Association Annual Meeting

Join us for a virtual press briefing to learn about highlights and key events of the APA Annual Meeting scheduled for May 5–9 in New York City. APA leadership will offer an overview of the meeting for media, including high-profile speakers and a preview of a new national public opinion survey on mental health.

MEDIA ADVISORY: Innovation Zone: What's Next in Mental Health Technology? American Psychiatric Association Annual Meeting

The American Psychiatric Association (APA) is hosting the 2018 Mental Health Innovation Zone presented by Takeda Pharmaceuticals, U.S.A, a showcase and catalyst for new mental health technologies, as part of its upcoming 2018 Annual Meeting.

Study Shows Fast-Acting Benefits of Ketamine for Depression and Suicidality; Caution on the Potential for Abuse and the Need for Effective Controls

A nasal spray formulation of ketamine shows promise in the rapid treatment of symptoms of major depression and suicidal thoughts, according to a new study published online today in The American Journal of Psychiatry (AJP).

APA Announces New Editor of American Journal of Psychiatry

The American Psychiatric Association (APA) announced today that Ned H. Kalin, M.D., will assume the role of Editor in Chief of the American Journal of Psychiatry (AJP) beginning Jan. 1, 2019.

APA Reflects on the Legacy of Former U.S. Sen. Daniel Akaka, Who Died at 93

Former U.S. Sen. Daniel Akaka of Hawaii passed away on April 6 at the age of 93. The senator, the first-ever native-born Hawaiian elected to Congress, was the uncle of American Psychiatric Association (APA) Board Member Jeff Akaka, M.D. The APA today issued this statement from CEO and Medical Director Saul Levin, M.D., M.P.A.:

APA Supports Surgeon General Recommendation to Widen Availability of Naloxone

Today U.S. Surgeon General Jerome Adams, M.D., M.P.H., issued a public health advisory urging more individual Americans to carry a dose of naloxone, a medication that can reverse the effects of an opioid overdose. Death rates from opioid overdoses have been increasing in recent years, and an estimated 2.1 million Americans have opioid use disorder. In response to the surgeon general’s public health advisory, the American Psychiatric Association (APA) issued the following statement from CEO and Medical Director Saul Levin, M.D., M.P.A.

APA CEO Reacts to Death of Foreign Service Officer Whose Organization Trained Thousands of Black Health Officials in South Africa

The American Psychiatric Association (APA) CEO and Medical Director Saul M. Levin, M.D., M.P.A., today made the following statement regarding the passing of Herbert Kaiser, 94, a retired Foreign Service officer who devoted his retirement to increasing the number of black health professionals in South Africa:

APA Reiterates Its Strong Opposition to Ban of Transgender Americans from Serving in U.S. Military

The APA today reiterated its strong opposition to a ban of transgender Americans from the U.S. military, first announced by President Trump in July of last year and brought to the forefront today with the release of a White House memo announcing that transgender individuals are disqualified from military services except under limited circumstances.

APA Praises Congress for Passing Omnibus Funding Bill That Addresses Mental Health and Substance Use Issues

The APA today praised Congress for passing the $1.3 trillion omnibus package that boosts funding for combating the opioids epidemic and for other pressing mental health and substance use issues facing the nation

APA Supports Participants in March for Our Lives Event

In advance of the March for Our Lives event on Saturday, March 24, in Washington, D.C., the American Psychiatric Association (APA) today released this statement

Media Contacts

Glenn O'Neal, 202-459-9732

Erin Connors, 202-609-7113